Preferred Equity Investment and Acquisition Financing of Genetic Testing Company for SBIC

We represented a small business investment company (SBIC) in making a subordinate term loan and preferred equity co-investment to fund a sponsor’s acquisition of a genetic testing and counseling company.

You Also May Be Interested In:

  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Client Type: Private Company